GlassScriptPhysician profile
Christopher Winthrop Ives
NPI 1477654010
$1,045.26
in general payments reported to CMS, 2019-2025
12 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.25 · 2020: $14.21 · 2021: $13.33 · 2022: $161 · 2023: $107 · 2024: $498 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737 · Gift: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.10 |
| Gift | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.96 | 2022-2025 | |
| Pfizer INC. | $178.41 | 2019-2025 | |
| Endogastric Solutions, INC | $99.29 | 2022 | |
| Axonics, INC. | $93.01 | 2024 | Axonics |
| Braintree Laboratories, INC. | $81.81 | 2023 | Sutab |
| Boston Scientific Corporation | $77.82 | 2024 | Resolution Clip, Rotatable Snare |
| Phathom Pharmaceuticals, INC. | $75.82 | 2025 | Voquezna |
| Amgen INC. | $75.31 | 2019-2024 | Otezla, Enbrel |
| Radius Health, INC. | $38.50 | 2023-2024 | Tymlos |
| Medtronic, INC. | $35.12 | 2024 | Ffrangio |
| Pharming Healthcare, INC. | $26.00 | 2022 | |
| Intercept Pharmaceuticals, INC. | $14.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ives listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.